Trial · NCT04978051
Registered outcomes20
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 20 of 20
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Efficacy of experimental treatment | up to 10 days | Number of patients reaching grade 2 (inpatient, no longer requiring supplemental oxygen and no longer requiring care or grade 1 (hospital discharge) of the ordinal scale of the clinical state of the patient for 48 hours. |
| Primary | Safety of experimental treatment | up to 10 days | Number of patients without an adverse reaction scoring 3, 4 or 5 according to the Criteria of Adverse Event Terminology (CTC-AE). |
| Secondary | Long-term efficacy | up to 10 days | Number (percentage) of patients who reach grade 2 or grade 1 during the 10 days of to have initiated treatment. |
| Secondary | Time to achive a clinical response | up to 40 days | period time (days) between visit 1 (treatment start visit) and the day of gathering sustained 48-hour grade 2, grade 1 or grade 0 classification on the WHO 8-point ordinal scale for clinical status assessment The patient must be discharged from the hospital by the 28th day without a relapse or comorbidity related to COVID-19 |
| Secondary | Time to achive an afebrile state | up to 40 days | period time (days) to reach a 48-hour sustained afebrile state (i.e., body temperature ≤ 37.5ºC) without antipyretic medication. |
| Secondary | time from symptom onset to treatment | up to day 1 | period time (days) between the first COVID-19-related symptom and visit 1 (treatment start visit). |
| Secondary | Responders | up to 40 days | Number (percentage) of patients considered as responders based on National Early Warning Score 2 (NEWS 2) |
| Secondary | COVID-19 related relapse | up to 40 days | number (and percentage) of patients discharged who presents any COVID-19-related relapse or comorbidity |
| Secondary | Patients with Adverse Events | up to 40 days | number of patients with Any Adverse Events |
| Secondary | Adverse Events | up to 40 days | Number of Adverse Events |
| Secondary | Serious Adverse Events | up to 40 days | Number of Serious Adverse Events |
| Secondary | Overall mortality | up to 40 days | number of patients who died |
| Secondary | COVID-19 related mortality | up to 40 days | number of patients who died due to COVID-19 |
| Secondary | Time until death | up to 40 days | number of days from visit 1 until death |
| Secondary | COVID-19-related complications | up to 40 days | number of patients who had any COVID-19 related complications |
| Secondary | Patients requiring intensive care | up to 40 days | number of patients who require intensive care |
| Secondary | patients requiring intensive care and invasive mechanical ventilation | up to 40 days | number of patients who require intensive care and invasive mechanical ventilation |
| Secondary | patients requiring oxygen supplementation | up to 40 days | number of patients who require oxygen supplementation from hospital discharge up until visit 7 |
| Secondary | Patients with nonsocomial infection | up to 40 days | number (and percentage) of patients diagnosed with another nosocomial infection |
| Secondary | Rehospitalizations | up to 40 days | number (and percentage) of patients who requires hospital readmission within 28 (± 3) days from hospital discharge |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04978051/registered